Sirolimus in Conjunction With Eylea vs Eylea Alone for Exudative AMD

NCT02732899 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

20

Enrollment

INDIV

Sponsor class

Conditions

Exudative Age Related Macular Degeneration

Interventions

DRUG: Sirolimus
DRUG: EYLEA

Sponsor

Maturi, Raj K., M.D., P.C.